This isn’t a heavily-traded stock, but its pattern is unusual enough to merit a post. Notice the intersection of those resistance lines. I’d say this is a powerful resistance zone for TBLA.

Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
This isn’t a heavily-traded stock, but its pattern is unusual enough to merit a post. Notice the intersection of those resistance lines. I’d say this is a powerful resistance zone for TBLA.

In spite of Apple’s shameless declaration it will engage in $110 billion of self-dealing by buying its own stock in the public market, that “investment” in their lame shares seems to have lost its verve, as all it accomplished was to seal a price gap. Big deal, Tim Apple. You can’t innovate your way out of a paper bag, so you have to resort to pathetic financial engineering instead.

In these trying times of relentless upticks, I might as well celebrate one of Slope’s better long ideas, which is Oscar Health. I suggested it a couple of weeks ago, and it continues to cruise higher:

Good morning, Slopers. As for the market this morning? SSDD! Since a lot of you missed it over this weekend, we have, for the first time in literally years, rolled out an update to our Android app. It’s fun, it’s fresh, and it’s free. If you have an Android device, please download it today and get the mobile Slope experience!

